269 related articles for article (PubMed ID: 3267225)
21. Frequent deletion and duplication of the steroid 21-hydroxylase genes.
Werkmeister JW; New MI; Dupont B; White PC
Am J Hum Genet; 1986 Oct; 39(4):461-9. PubMed ID: 3490178
[TBL] [Abstract][Full Text] [Related]
22. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
23. Exon 7 Ncol restriction site within CYP21B (steroid 21-hydroxylase) is a normal polymorphism.
Donohoue PA; Sandrini Neto R; Collins MM; Migeon CJ
Mol Endocrinol; 1990 Sep; 4(9):1354-62. PubMed ID: 1978247
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of polymorphic 21-hydroxylase gene (CA21HB) mutations in salt-losing congenital adrenal hyperplasia.
Jospe N; Donohoue PA; Van Dop C; McLean RH; Bias WB; Migeon CJ
Biochem Biophys Res Commun; 1987 Feb; 142(3):798-804. PubMed ID: 3030300
[TBL] [Abstract][Full Text] [Related]
25. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction.
Owerbach D; Ballard AL; Draznin MB
J Clin Endocrinol Metab; 1992 Mar; 74(3):553-8. PubMed ID: 1740489
[TBL] [Abstract][Full Text] [Related]
26. 21-hydroxylase deficiency: disease-causing mutations categorized by densitometry of 21-hydroxylase-specific deoxyribonucleic acid fragments.
Haglund-Stengler B; Ritzén EM; Luthman H
J Clin Endocrinol Metab; 1990 Jan; 70(1):43-8. PubMed ID: 2152933
[TBL] [Abstract][Full Text] [Related]
27. Major-histocompatibility-complex gene markers and restriction-fragment analysis of steroid 21-hydroxylase (CYP21) and complement C4 genes in classical congenital adrenal hyperplasia patients in a single population.
Partanen J; Koskimies S; Sipilä I; Lipsanen V
Am J Hum Genet; 1989 May; 44(5):660-70. PubMed ID: 2565078
[TBL] [Abstract][Full Text] [Related]
28. Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasia.
Azziz R; Wells G; Acton RT; Zacur HA
Am J Obstet Gynecol; 1990 Mar; 162(3):633-8. PubMed ID: 2316563
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathology of 21-hydroxylase deficiency.
Strachan T
J Inherit Metab Dis; 1994; 17(4):430-41. PubMed ID: 7967493
[TBL] [Abstract][Full Text] [Related]
30. Nonisotopic identification of two point mutations in the CYP21 gene responsible for nonclassic 21-hydroxylase deficiency.
Shevtsov SP; Rechitsky S; Verlinsky O; Schwartz EI
Biochem Med Metab Biol; 1994 Aug; 52(2):85-8. PubMed ID: 7993665
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics of congenital adrenal hyperplasia.
White PC; New MI
Baillieres Clin Endocrinol Metab; 1988 Nov; 2(4):941-65. PubMed ID: 3077248
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of steroid 21-hydroxylase genes in classical congenital adrenal hyperplasia.
Dawkins RL; Martin E; Kay PH; Garlepp MJ; Wilton AN; Stuckey MS
J Immunogenet; 1987; 14(2-3):89-98. PubMed ID: 2891769
[TBL] [Abstract][Full Text] [Related]
33. CYP21B gene conversion and complete CYP21A gene deletion in congenital adrenal hyperplasia.
Lobaccaro JM; Ghanem N; Lefranc G; Sultan C
Ann Genet; 1990; 33(2):70-5. PubMed ID: 1978631
[TBL] [Abstract][Full Text] [Related]
34. Linkage between I172N mutation, a marker of 21-hydroxylase deficiency, and a single nucleotide polymorphism in Int6 of CYP21B gene: a genetic study of Sardinian family.
Concolino P; Satta MA; Santonocito C; Carrozza C; Rocchetti S; Ameglio F; Giardina E; Zuppi C; Capoluongo E
Clin Chim Acta; 2006 Feb; 364(1-2):298-302. PubMed ID: 16171792
[TBL] [Abstract][Full Text] [Related]
35. [Molecular analysis of the most frequent mutations associated with congenital adrenal hyperplasia secondary to 21-hydroxylase enzyme deficiency].
Dardis A; Marino R; Bergadá I; Escobar ME; Gryngarten M; Rivarola MA; Belgorosky A
Medicina (B Aires); 2001; 61(1):28-34. PubMed ID: 11265620
[TBL] [Abstract][Full Text] [Related]
36. A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome.
Collier S; Tassabehji M; Sinnott P; Strachan T
Nat Genet; 1993 Mar; 3(3):260-5. PubMed ID: 8485582
[TBL] [Abstract][Full Text] [Related]
37. Preliminary investigation of mutations in 21-hydroxylase gene in patients with congenital adrenal hyperplasia in Russia.
Evgrafov OV; Polyakov AV; Dzenis IG; Baharev VA
Hum Mutat; 1995; 5(2):131-6. PubMed ID: 7749411
[TBL] [Abstract][Full Text] [Related]
38. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations.
Wedell A; Ritzén EM; Haglund-Stengler B; Luthman H
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7232-6. PubMed ID: 1496017
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathology of steroid 21-hydroxylase deficiency.
Strachan T; White PC
J Steroid Biochem Mol Biol; 1991; 40(4-6):537-43. PubMed ID: 1958556
[TBL] [Abstract][Full Text] [Related]
40. Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein.
Donohoue PA; van Dop C; McLean RH; White PC; Jospe N; Migeon CJ
J Clin Endocrinol Metab; 1986 May; 62(5):995-1002. PubMed ID: 3007562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
